13 Research methods, statistics, critical review and evidence-based practice13.1 Introductory concepts

13.1.5 Formulating clinical questions

3 min read

Written by Resident Doctor Committee · Published

Try it

Which study design answers this question?

Interactive

What do you want to find out?

There is no best design, only a design that fits the question. In the exam, read the question's aim first and the options second.

Run the tree twice: first for "does melatonin prevent delirium", then for "what is this patient's risk of delirium". It lands on a different design each time.

Formulating an answerable PECO(T) question

The PICO format

PICO (population, intervention, comparator, outcome) turns a clinical uncertainty into a focused, answerable and searchable question. It is framed before the literature search begins.

Element

Meaning

Population

The group of patients being asked about

Intervention or exposure

The treatment, test, risk factor or service model

Comparator

The alternative it is weighed against: another treatment, usual care, placebo or nothing

Outcome

The benefits and harms the patient cares about

  • Population should include only features that could change the answer, such as treatment resistance in a clozapine question.

  • PECO is the exposure-based variant: patient or population, exposure, comparison, outcome. It fits aetiology, harm and some prognostic questions.

Choosing the comparator

  • For the risk of a drug side effect, the comparator is people with the same condition who are not exposed to the drug. This isolates the drug's contribution and mirrors the patient's decision to start it or not.

  • Placebo differs from doing nothing, because it carries the context and expectations of treatment.

  • A descriptive prognosis question may need no comparator.

Outcome and time

  • A rating-scale change can be statistically significant yet too small to matter, so judge it against the minimal clinically important difference.

  • State the follow-up when it changes the interpretation, above all for relapse or death.

Related frameworks

Framework

What it adds or uses

Fits

PICOT or PECOT

Time

Questions affected by follow-up duration

PICOS

Study design

Systematic review eligibility criteria

SPIDER

Sample, phenomenon of interest, design, evaluation, research type

Qualitative questions

SPICE

Setting, perspective, intervention, comparison, evaluation

Questions needing an explicit setting and perspective

Types of clinical question

Background and foreground questions

  • Background questions ask for general knowledge about a disorder: its features, causes, frequency or mechanism. They frame no population, intervention or exposure, comparison or outcome.

  • Foreground questions are specific and patient-oriented, naming a defined population, intervention, comparison and outcome so that the answer informs a clinical decision.

Question types and matching designs

Type

What it asks

Best matched design

Typical effect measure

Therapy

Does an intervention help?

Randomised controlled trial (RCT), or systematic review of RCTs

Risk ratio, absolute risk reduction, mean difference

Harm

What adverse effects follow?

Large cohort, linked routine data, pharmacovigilance registry

Risk ratio, incidence

Aetiology

Does a factor cause the outcome?

Triangulated observational evidence, Mendelian randomisation where relevant

Risk ratio, odds ratio

Prognosis

Does a factor predict the outcome?

Inception cohort

Absolute risk, hazard ratio

Diagnosis

How accurate is a test?

Comparison with a reference standard

Sensitivity, specificity, likelihood ratios

Economic

How do costs compare with outcomes?

Purpose-built economic evaluation

Cost per quality-adjusted life year

Qualitative

What do people experience, and why?

Interviews, focus groups, observation

Themes, not a numerical effect size

  • Prognostic factors need not be causal, so a predictor does not show that changing it would change the outcome.

Event rates in trials

  • The control event rate and experimental event rate are the percentages of each trial arm who have an event on a dichotomous (yes or no) outcome.

  • Relative risk is derived from the two rates, but the rates on their own are not measures of benefit.